Jefferies Downgrades Atara Biotherapeutics (ATRA) to Hold

Jefferies analyst Maury Raycroft downgraded Atara Biotherapeutics (NASDAQ: ATRA) from Buy to Hold with a price target of $15.00 (from $32.00).

For an analyst ratings summary and ratings history on Atara Biotherapeutics click here. For more ratings news on Atara Biotherapeutics click here.

Shares of Atara Biotherapeutics closed at $15.16 yesterday.

You May Also Be Interested In

• Canaccord Downgrades York Space Systems (YSS) to Hold, 'Supply chain and contract timing uncertainty'
• Samsonite International SA (1910:HK) (SMSEY) PT Lowered to HK$19.60 at Macquarie
• argenx SE (ARGX) PT Raised to $1,353 at TD Cowen